Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD

    Clinical Journal of the American Society of Nephrology Date published:

  • Risk of Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

    Arthritis & Rheumatology Date published:

  • Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry

    Kidney International Reports Date published:

  • Not enough known about fenofibrate’s kidney effects in people with Type 2 diabetes

    Diabetes Research and Clinical Practice Date published:

  • Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

    Kidney International Supplements Date published:

  • Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

    The Lancet Regional Health - Western Pacific Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

    Kidney International Reports Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Kidney International Reports Date published:

  • The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

    International Journal of Cardiology Date published:

  • Alternative klinische Studiendesigns für die Nephrologieforschung

    Innovationen in der Nephrologie Date published:

  • Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

    Canadian Journal of Kidney Health and Disease Date published:

  • Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points

    Clinical Journal of the American Society of Nephrology Date published:

  • Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team

    Journal of the American Society of Nephrology Date published:

  • Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    The Lancet Date published:

  • Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort

    Journal of the American Society of Nephrology Date published: